Authors:
Icli, F
Akbulut, H
Dincol, D
Onur, H
Demirkazik, A
Cam, R
Cay, F
Demirci, S
Uner, A
Erekul, S
Citation: F. Icli et al., A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer, ANN ONCOL, 12(7), 2001, pp. 1011-1013
Authors:
Emri, S
Akbulut, H
Zorlu, F
Dincol, D
Akay, H
Gungen, Y
Icli, F
Citation: S. Emri et al., Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma, LUNG CANC, 33(2-3), 2001, pp. 109-114
Authors:
Dincol, D
Samur, M
Pamir, A
Sencan, O
Akbulut, H
Yalcin, B
Onur, H
Demirkazik, A
Senler, FC
Icli, F
Citation: D. Dincol et al., Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma, CANCER, 88(9), 2000, pp. 2033-2036
Citation: S. Atahan et al., Cytology of clear cell carcinoma of the female genital tract in fine needle aspirates and ascites, ACT CYTOL, 44(6), 2000, pp. 1005-1009
Authors:
Arican, A
Icli, F
Akbulut, H
Cakir, M
Sencan, O
Samur, M
Acikgoz, N
Demirkazik, A
Citation: A. Arican et al., The effect of two different doses of oral clodronate on pain in patients with bone metastases, MED ONCOL, 16(3), 1999, pp. 204-210
Authors:
Akbulut, H
Icli, F
Buyukcelik, A
Akbulut, KG
Demirci, S
Citation: H. Akbulut et al., The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer, J PINEAL R, 26(1), 1999, pp. 1-8
Authors:
Arican, A
Dincol, D
Akbulut, H
Onur, H
Demirkazik, A
Cay, F
Icli, F
Citation: A. Arican et al., Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey, AM J CL ONC, 22(6), 1999, pp. 587-592
Authors:
Icli, F
Arican, A
Cay, F
Akbulut, H
Dincol, D
Karaoguz, H
Demirkazik, A
Citation: F. Icli et al., Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil, ONCOL-BASEL, 56(4), 1999, pp. 297-300
Authors:
Icli, F
Celik, I
Aykan, F
Uner, A
Demirkazik, A
Ozet, A
Ozguroglu, M
Tas, F
Akbulut, H
Firat, D
Citation: F. Icli et al., A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma, CANCER, 83(12), 1998, pp. 2475-2480